Literature DB >> 16861151

Combined cannabis/methaqualone withdrawal treated with psychotropic analgesic nitrous oxide.

Mark A Gillman1, Nadine Harker, Frederick J Lichtigfeld.   

Abstract

This article reports the first single-blind study using psychotropic analgesic nitrous oxide (PAN) for treating acute withdrawal states following the abuse of methaqualone combined and smoked with cannabis. Smoked methaqualone combined with cannabis is called "white pipe" (WP). South Africa is the only country in the world where WP is a major form of substance abuse. This article demonstrates in 101 consecutively treated patients given placebo (100% oxygen) followed by PAN that this therapy produced a measurable therapeutic effect (more than 50% improvement) in 87 patients. This study confirms that WP is a form of substance abuse confined mainly to young adult male subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861151     DOI: 10.1080/00207450600753998

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  5 in total

1.  Suffocation caused by plastic wrap covering the face combined with nitrous oxide inhalation.

Authors:  Peter Mygind Leth; Birgitte Schmidt Astrup
Journal:  Forensic Sci Med Pathol       Date:  2017-06-19       Impact factor: 2.007

2.  Nitrous oxide inhalation among adolescents: prevalence, correlates, and co-occurrence with volatile solvent inhalation.

Authors:  Eric L Garland; Matthew O Howard; Brian E Perron
Journal:  J Psychoactive Drugs       Date:  2009-12

Review 3.  Pharmacotherapies for cannabis dependence.

Authors:  Kushani Marshall; Linda Gowing; Robert Ali; Bernard Le Foll
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

4.  What is better for psychiatry: Titrated or fixed concentrations of nitrous oxide?

Authors:  Mark A Gillman
Journal:  Front Psychiatry       Date:  2022-08-22       Impact factor: 5.435

5.  Pharmacotherapies for cannabis dependence.

Authors:  Suzanne Nielsen; Linda Gowing; Pamela Sabioni; Bernard Le Foll
Journal:  Cochrane Database Syst Rev       Date:  2019-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.